drugset

drugset / Trial / NCT00365820

Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

NCT00365820 ↗

Phase 2/3 Terminated 670 enrolled Novartis

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy and safety of tegaserod in opioid-induced constipation in patients with non-cancer pain.

Timeline

Start: 2006-07
Primary completion: 2007-04
Completion: 2007-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tegaserod	Small molecule	—	Oral

Indications